User profiles for Lior Nesher
 | Lior NesherAssociate Professor of Medicine, Ben-Gurion University of the Negev Verified email at bgu.ac.il Cited by 2638 |
[HTML][HTML] BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
…, M Chowers, M Elbaz, L Nesher… - Clinical Microbiology …, 2021 - Elsevier
Objectives The mRNA coronavirus disease 2019 (COVID-19) vaccines have shown high
effectiveness in the prevention of symptomatic COVID-19, hospitalization, severe disease and …
effectiveness in the prevention of symptomatic COVID-19, hospitalization, severe disease and …
Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
Vaccination, especially with multiple doses, provides substantial population-level protection
against COVID-19, but emerging variants of concern (VOC) and waning immunity represent …
against COVID-19, but emerging variants of concern (VOC) and waning immunity represent …
The current spectrum of infection in cancer patients with chemotherapy related neutropenia
L Nesher, KVI Rolston - Infection, 2014 - Springer
Despite advancements in the treatment and supportive care of patients with malignant
disorders, neutropenia remains the major side effect of most antineoplastic regimens. Infections …
disorders, neutropenia remains the major side effect of most antineoplastic regimens. Infections …
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers
Recent reports suggest that 10 to 30% of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infected patients are asymptomatic and that viral shedding may occur before …
CoV-2) infected patients are asymptomatic and that viral shedding may occur before …
Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review
EJ Ariza-Heredia, L Nesher, RF Chemaly - Cancer letters, 2014 - Elsevier
Cytomegalovirus (CMV) infection remains a significant complication after hematopoietic
stem cell transplantation (HSCT) and may have a deleterious impact on the overall outcome …
stem cell transplantation (HSCT) and may have a deleterious impact on the overall outcome …
Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy
L Nesher, KVI Rolston - Clinical infectious diseases, 2013 - academic.oup.com
Neutropenic enterocolitis (NEC) is a life-threatening disease with substantial morbidity and
mortality, seen primarily in patients with hematologic malignancies. The frequency of NEC …
mortality, seen primarily in patients with hematologic malignancies. The frequency of NEC …
Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
C Bartal, KVI Rolston, L Nesher - Infectious diseases and therapy, 2022 - Springer
Carbapenem-resistant Acinetobacter baumannii (CRAB) causes colonization and infection
predominantly in hospitalized patients. Distinction between the two is a challenge. When …
predominantly in hospitalized patients. Distinction between the two is a challenge. When …
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
We developed an immunodeficiency scoring index for respiratory syncytial virus (ISI-RSV)
infection, based on a cohort of 237 allogeneic hematopoietic cell transplant (allo-HCT) …
infection, based on a cohort of 237 allogeneic hematopoietic cell transplant (allo-HCT) …
Utility of the enzyme-linked immunospot interferon-γ–release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients
The ability to distinguish allogeneic hematopoietic cell transplant (allo-HCT) recipients at risk
for cytomegalovirus (CMV) reactivation from those who are not is central for optimal CMV …
for cytomegalovirus (CMV) reactivation from those who are not is central for optimal CMV …
The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients
…, D El-Haddad, A Prayag, L Nesher… - The Journal of …, 2019 - academic.oup.com
Background Cytomegalovirus (CMV) infections in hematopoietic cell transplant (HCT) recipients
cause substantial morbidity and mortality. CMV cell-mediated immunity (CMV-CMI) can …
cause substantial morbidity and mortality. CMV cell-mediated immunity (CMV-CMI) can …